Frontlight ResearchEarly access
CompletedPhase 4
Atorvastatin Therapy in the Treatment of Dyslipidemia in Children With Steroid Sensitive Nephrotic Syndrome
Key facts
- Who runs it
- National Institute of Kidney Disease and Urology (NIKDU)
- Where
- Bangladesh1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 4
- People taking part
- 100 people enrolled
- Started
- 27 Jan 2024
- Ended
- 31 Oct 2025
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Atorvastatin
- Record updated
- 27 March 2026
Who can take part
- Age
- 8 years to 18 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (9)Hide the full registry criteria
Who can take part
- Children aged 8-18 years with known cases of steroid sensitive nephrotic syndrome
- LDL ≥ 130 mg/dl in two consecutive serum fasting lipid profile, at least 4 weeks apart
- while on remission
- free of acute infection
Who cannot take part
- Children with previously diagnosed hyperlipidemia other than Nephrotic Syndrome
- Children already on lipid lowering drugs
- Children with steroid resistant nephrotic syndrome
- Secondary nephrotic syndrome
- Those parents/patients who refused to participate; Secondary nephrotic syndrome (SLE, amyloidosis etc.) 5. Nephrotic syndrome (initial episode). 6. Children taking Anti TB drug or anticonvulsant drugs. 7. Children having any active liver disease
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
To evaluate the effectiveness and safety of Atorvastatin therapy in children with dyslipidemia in steroid sensitive nephrotic syndrome.
The 2 groups in the trial
- Control arm/Placebo armNo study treatment, for comparison
Dietary Advice
- Intervention arm/ AtorvastatinTreatment being tested
Dietary advice plus atorvastatin
Treatment: Atorvastatin
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 27 March 2026